Palo Alto, CA, United States of America

Michael Lloyd Radomsky


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 79(Granted Patents)


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Michael Lloyd Radomsky

Introduction

Michael Lloyd Radomsky is an accomplished inventor based in Palo Alto, California. He has made significant contributions to the field of pharmaceuticals, particularly in the area of nasal delivery systems for therapeutic compounds.

Latest Patents

Radomsky holds a patent for a pharmaceutical composition designed for the nasal delivery of compounds useful in treating osteoporosis. This innovative formulation includes an effective amount of a physiologically active truncated analog of PTH or PTHrp, or a salt thereof. The composition is characterized by specific amino acid residues that form an amphipathic alpha-helix, selected from a defined sequence. Additionally, it incorporates an absorption enhancer, such as dimethyl-beta-cyclodextrin or bile acid surfactants, along with water.

Career Highlights

Throughout his career, Radomsky has focused on developing advanced pharmaceutical solutions that enhance drug delivery and efficacy. His work has the potential to improve treatment options for patients suffering from osteoporosis, showcasing his commitment to innovation in healthcare.

Collaborations

Radomsky has collaborated with notable professionals in his field, including Christin Teresa Piazza and John L Krstenansky. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Michael Lloyd Radomsky's contributions to pharmaceutical innovations highlight his expertise and dedication to improving healthcare solutions. His work continues to pave the way for advancements in drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…